Your browser doesn't support javascript.
loading
Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study.
Kato, Renpei; Naito, Sei; Numakura, Kazuyuki; Hatakeyama, Shingo; Koguchi, Tomoyuki; Kojima, Takahiro; Kawasaki, Yoshihide; Kandori, Shuya; Kawamura, Sadafumi; Arai, Yoichi; Ito, Akihiro; Nishiyama, Hiroyuki; Kojima, Yoshiyuki; Ohyama, Chikara; Habuchi, Tomonori; Tsuchiya, Norihiko; Obara, Wataru.
Afiliação
  • Kato R; Department of Urology, Iwate Medical University School of Medicine, 2-1-1 Idaidori, Yahaba-cho, Shiwa, 028-3695, Japan. rekato@iwate-med.ac.jp.
  • Naito S; Department of Urology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.
  • Numakura K; Department of Urology, Akita University School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
  • Hatakeyama S; Department of Urology and Advanced Blood Purification Therapy, Hirosaki University Graduate of Medicine, 5 Zaifuchou, Hirosaki, 036-8562, Japan.
  • Koguchi T; Department of Urology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Kojima T; Department of Urology, University of Tsukuba Graduate School of Medicine, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.
  • Kawasaki Y; Department of Urology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
  • Kandori S; Department of Urology, University of Tsukuba Graduate School of Medicine, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.
  • Kawamura S; Department of Urology, Miyagi Cancer Center, 47-1, Nodayama, Shiote, Aijima, Natori, 981-1293, Japan.
  • Arai Y; Department of Urology, Miyagi Cancer Center, 47-1, Nodayama, Shiote, Aijima, Natori, 981-1293, Japan.
  • Ito A; Department of Urology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
  • Nishiyama H; Department of Urology, University of Tsukuba Graduate School of Medicine, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.
  • Kojima Y; Department of Urology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Ohyama C; Department of Urology and Advanced Blood Purification Therapy, Hirosaki University Graduate of Medicine, 5 Zaifuchou, Hirosaki, 036-8562, Japan.
  • Habuchi T; Department of Urology, Akita University School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
  • Tsuchiya N; Department of Urology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.
  • Obara W; Department of Urology, Iwate Medical University School of Medicine, 2-1-1 Idaidori, Yahaba-cho, Shiwa, 028-3695, Japan.
Int J Clin Oncol ; 27(3): 563-573, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34973106
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article